Hofheinz, RD; Wenz, F; Lukan, N et al.
Oxaliplatin and capecitabine-based chemoradiotherapy for gastric cancer-an extended phase I MARGIT and AIO trialInt J Radiat Oncol Biol Phys. Bd. 73. H. 1. 2009 S. 142-7
Hegewisch-Becker, S; Vanhoefer, U; Kubicka, S et al.
Palliative treatment for colorectal cancerOnkologie. Bd. 32. H. 2. 2009 S. 13-6
Herzer, K; Carbow, A; Weyer, S et al.
PML-DEFICIENCY DETERMINES LIVER TUMOR DEVELOPMENT IN CHRONIC HCV INFECTIONHEPATOLOGY. Bd. 50. H. 4. 2009 S. 930A-931A
Marker-Hermann, E; Schmidt, WA
Polymyalgia rheumaticaDEUTSCHE MEDIZINISCHE WOCHENSCHRIFT. Bd. 134. H. 4. 2009 S. 135-142
Zimmermann, T; Tripkovic, V; Hoppe-Lotichius, M et al.
POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS (PTLD) IN ADULT LIVER TRANSPLANTED PATIENTS WITH IMMUNOLOGICAL DISEASESLIVER TRANSPLANTATION. Bd. 15. H. 7. 2009 S. S198-S198
Gockel, I; Domeyer, M; Sgourakis, GG et al.
Prediction model of lymph node metastasis in superficial esophageal adenocarcinoma and squamous cell cancer including D2-40 immunostaining.J Surg Oncol. Bd. 100. H. 3. 2009 S. 191-8
Dunst, J; Hohler, T; Reese, T et al.
Preoperative radiochemotherapy with bevacizumab and capecitabin/Oxaliplatin in locally advanced rectum carcinoma: first toxicity data of a multicentric phase II-studySTRAHLENTHERAPIE UND ONKOLOGIE. Bd. 185. 2009 S. 104-104
Waisman, A; Freese, S; Buch, T et al.
PRIMARY OLIGODENDROPATHY IS NOT A TRIGGER OF CNS INFLAMMATIONGLIA. Bd. 57. H. 13. 2009 S. S13-S13
Becker, C; Taube, C; Bopp, T et al.
Protection from graft-versus-host disease by HIV-1 envelope protein gp120-mediated activation of human CD4(+)CD25(+) regulatory T cellsBLOOD. Bd. 114. H. 6. 2009 S. 1263-1269
Marker-Hermann, E; Behrens, F
Psoriatic arthritis. Treatment outcome parametersZEITSCHRIFT FUR RHEUMATOLOGIE. Bd. 68. H. 1. 2009 S. 16-+